{"id":"W3088162954","doi":"10.1016/j.annonc.2020.08.675","title":"561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Oncology; Regimen; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Trametinib; Adverse effect; Gastroenterology; Urology; Chemotherapy; Kinase; MAPK/ERK pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007393806,0.001303817,0.001707926,0.0003174465,0.0003443607,0.001194141,0.0006518638,0.0008997601,0.006570842],"category_scores_gemma":[0.0005969623,0.0005271336,0.001266862,0.0003673492,0.0006243016,0.0006823149,0.0003785192,0.003017701,0.002226695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001070625,"about_ca_system_score_gemma":0.001507352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002073063,"about_ca_topic_score_gemma":0.004572503,"domain_scores_codex":[0.9997991,0.00006288129,0.000009678962,0.00004034212,0.00001858328,0.00006950017],"domain_scores_gemma":[0.9997775,0.00002478907,0.00004057496,0.00001765587,0.00001358285,0.0001259874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7390671,0.02345683,0.005338414,0.001359711,0.001450224,0.000361974,0.0002239492,0.005138296,0.05805054,0.0005882078,0.01202761,0.1529372],"study_design_scores_gemma":[0.6473956,0.3117453,0.01764438,0.0001067992,0.001114663,0.0008450944,0.0001307543,0.002480933,0.0060132,0.0005175216,0.01193556,0.00007012964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836668,0.002603445,0.0004307988,0.0009519192,0.000239855,0.001692155,0.003495002,0.000213138,0.006706943],"genre_scores_gemma":[0.9738807,0.00390578,0.00144131,0.001115372,0.0001585237,0.001560978,0.007437344,0.00007738283,0.01042267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006570842,"threshold_uncertainty_score":0.02198166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09530483402239531,"score_gpt":0.4358727483727366,"score_spread":0.3405679143503413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}